SciSparc (SPRC) Depreciation & Amortization (CF) (2016 - 2018)
SciSparc (SPRC) posted Depreciation & Amortization (CF) of $137000.0 for Q4 2018, up 3325.0% sequentially from $4000.0 in Q3 2018, and up 13600.0% YoY from N/an in Q4 2017.
SciSparc (SPRC) Depreciation & Amortization (CF) (2016 - 2018) Analysis & Trends
SciSparc has reported Depreciation & Amortization (CF) for 3 years, with the latest figure at $137000.0 in Q4 2018.
- Quarterly Depreciation & Amortization (CF) rose 13600.0% year-over-year to $137000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2019 was $137000.0 (down 6.8% YoY) and the FY2024 annual result came in at $482000.0, down 10.41% from the prior year.
- Depreciation & Amortization (CF) grew to $137000.0 in Q4 2018 per SPRC's latest filing, from $4000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $137000.0 in Q4 2018 and troughed at $1000.0 in Q3 2016.
- A 3-year average of $15500.0 and a median of $2000.0 in 2016 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2017 and 2018: Depreciation & Amortization (CF) plunged 50.0% in 2017, then surged 13600.0% in 2018.
- Over 3 years, Depreciation & Amortization (CF) stood at $1000.0 in 2016, then changed by 0.0% to $1000.0 in 2017, then soared by 13600.0% to $137000.0 in 2018.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $137000.0, $4000.0, and $3000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 137,000.00 |
| Dec 31, 2018 | 137,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Sep 30, 2017 | 2,000.00 |
| Sep 30, 2017 | 2,000.00 |
| Jun 30, 2017 | 1,000.00 |
| Jun 30, 2017 | 1,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 2,000.00 |
| Jun 30, 2016 | 2,000.00 |